Patent ID: 7713964

Claim:
A method of treatment of asthma in a mammal, the method comprising administering to a mammal in need thereof a pharmaceutically effective amount of a compound of the formula: wherein: R is —(CH 2 ) n -A, wherein A is: wherein B and C are each phenyl, each independently optionally substituted by from 1 to 3 substituents selected independently from halogen, —CN, —CHO, —CF 3 , —OCF 3 , —OH, —C 1 -C 6 alkyl, C 1 -C 6 alkoxy, —NH 2 , —N(C 1 -C 6 alkyl) 2 , —NH(C 1 -C 6 alkyl), —NH—C(O)—(C 1 -C 6 alkyl), and —NO 2 ; n is an integer from 0 to 3; n 1 is an integer from 1 to 3; n 2 is an integer from 0 to 4; n 3 is an integer from 0 to 3; n 4 is an integer from 0 to 2; X 1 is selected from a chemical bond, —S—, —O—, —S(O)—, —S(O) 2 —, —NH—, —NHC(O)—, —C═C—, R 1 is selected from C 1 -C 6 alkyl, C 1 -C 6 fluorinated alkyl, C 3 -C 6 cycloalkyl, tetrahydropyranyl, camphoryl, adamantyl, CN, —N(C 1 -C 6 alkyl) 2 , phenyl, pyridinyl, pyrimidinyl, furyl, thienyl, napthyl, morpholinyl, triazolyl, pyrazolyl, piperidinyl, pyrrolidinyl, imidazolyl, piperazinyl, thiazolidinyl, thiomorpholinyl, tetrazolyl, indolyl, benzoxazolyl, benzofuranyl, imidazolidine-2-thionyl, 7,7-dimethyl-bicyclo[2.2.1]heptan-2-onyl, benzo[1,2,5]oxadiazolyl, 2-oxa-5-aza-bicyclo[2.2.1]heptanyl, piperazin-2-onyl, and pyrrolyl groups, each optionally substituted by from 1 to 3 substituents independently selected from halogen, —CN, —CHO, —CF 3 , —OCF 3 , —OH, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, —NH 2 , —N(C 1 -C 6 alkyl) 2 , —NH(C 1 -C 6 alkyl), —NH—C(O)—(C 1 -C 6 alkyl), —NO 2 , —SO 2 (C 1 -C 3 alkyl, —SO 2 NH 2 , —SO 2 NH(C 1 -C 3 alkyl), —SO 2 N(C 1 -C 3 alkyl) 2 , —COOH, —CH 2 —COOH, —CH 2 —NH(C 1 -C 6 alkyl), —CH 2 —N(C 1 -C 6 alkyl) 2 , —CH 2 —NH 2 , pyridinyl, 2-methyl-thiazolyl, morpholino, 1-chloro-2-methyl-propyl, C 1 -C 6 thioalkyl, phenyl (further optionally substituted with one or more halogens), benzyloxy, —(C 1 -C 3 alkyl)C(O)CH 3 , —(C 1 -C 3 alkyl)OCH 3 , —C(O)NH 2 , X 2 is selected from —O—, —CH 2 —, —S—, —SO—, —SO 2 —, —NH—, —C(O)—, R 2 is phenyl substituted by a group of the formula —(CH 2 ) n4 —CO 2 H or a pharmaceutically acceptable acid mimic or mimetic; and also optionally substituted by 1 or 2 additional substituents independently selected from halogen, —CN, —CHO, —CF 3 , —OCF 3 , —OH, —C 1 -C 6 alkyl, C 1 -C 6 alkoxy, C 1 -C 6 thioalkyl, —NH 2 , —N(C 1 -C 6 alkyl) 2 , —NH(C 1 -C 6 alkyl), —NH—C(O)—(C 1 -C 6 alkyl), and —NO 2 ; R 3 is H, halogen, —CN, —CHO, —CF 3 , —OCF 3 , —OH, —C 1 -C 6 alkyl, C 1 -C 6 alkoxy, C 1 -C 6 thioalkyl, —NH 2 , —N(C 1 -C 6 alkyl) 2 , —NH(C 1 -C 6 alkyl), —NH—C(O)—(C 1 -C 6 alkyl), or —NO 2 ; and R 4 is H, halogen, —CN, —CHO, —CF 3 , —OCF 3 , —OH, —C 1 -C 6 alkyl, C 1 -C 6 alkoxy, C 1 -C 6 thioalkyl, —NH 2 , —N(C 1 -C 6 alkyl) 2 , —NH(C 1 -C 6 alkyl), —NH—C(O)—(C 1 -C 6 alkyl), —NO 2 , morpholino, pyrrolidino, piperidinyl, or piperizinyl; or a pharmaceutically acceptable salt thereof.